How to Figure BMI Index: Formula and Ranges

How to figure BMI index is a common question, and the calculation itself is straightforward: divide your weight in kilograms by the square of your height in metres. The resulting number places you within one of four standard categories used by the NHS and NICE to indicate broad levels of weight-related health risk. Understanding what your BMI means, where it falls short, and what to do next are equally important steps. This article explains the calculation, the UK reference ranges, the limitations of BMI as a measure, and when to seek professional advice.

How do you work out your BMI?

BMI is calculated by dividing your weight in kilograms by the square of your height in metres. The NHS provides a free online calculator at nhs.uk that accepts both metric and imperial measurements.

BMI (body mass index) is calculated by dividing your weight in kilograms by the square of your height in metres.^[1][2] The result is expressed in kg/m2, though most patient-facing tools display it as a plain number. For example, if you weigh 80 kg and are 1.75 m tall, the calculation is: 80 divided by (1.75 multiplied by 1.75), which gives a BMI of approximately 26.1 kg/m2.

To work through the steps clearly:

• Measure your height in metres (for example, 1.68 m)

• Measure your weight in kilograms

• Square your height (multiply it by itself: 1.68 x 1.68 = 2.82)

• Divide your weight by that figure (for example, 70 kg divided by 2.82 = 24.8)

The NHS provides a free online BMI calculator at nhs.uk, which accepts both metric and imperial measurements and places your result within the standard UK reference ranges. If you prefer to use pounds and inches, the NHS calculator handles the conversion for you.

It is worth noting that BMI is a population-level screening tool rather than a diagnostic test. It was developed in the nineteenth century as a statistical measure and has since been adopted by public health bodies, including NICE and the NHS, as a practical first step in assessing weight-related health risk.^[17] While straightforward to calculate, BMI does not capture the full picture of an individual's health, a point explored in more detail below.

What do the BMI ranges actually mean for your health?

NHS and NICE classify adult BMI into four categories, with a BMI above 25 linked to progressively increased risk of type 2 diabetes, cardiovascular disease and other conditions. These ranges do not apply to under-18s, who are assessed using age- and sex-specific centile charts.

The NHS and NICE use four standard BMI categories to indicate broad levels of weight-related health risk in adults. For most adults in the UK, the ranges are as follows:

• Below 18.5: Underweight

• 18.5 to 24.9: Healthy weight

• 25.0 to 29.9: Overweight

• 30.0 and above: Obese (further subdivided into Class I, II and III)

These thresholds are not arbitrary. Research consistently links a BMI above 25 with a progressively increased risk of conditions including type 2 diabetes, cardiovascular disease, certain cancers, sleep apnoea and joint problems.^[18] Conversely, a BMI below 18.5 is associated with nutritional deficiencies, reduced bone density and impaired immune function.

Within the obese range, NICE guidance distinguishes between Class I (BMI 30 to 34.9), Class II (35 to 39.9) and Class III (40 and above), sometimes referred to as severe obesity. Note that "severe and complex obesity" is a separate service and pathway term used by NICE and NHS England, and is not simply interchangeable with Class III.

BMI categories for children and young people are assessed differently: rather than fixed thresholds, clinicians use age- and sex-specific centile charts, so the adult ranges described here do not apply to under-18s.

It is important to understand that these ranges describe statistical associations across large populations. An individual's actual health risk depends on many additional factors, including where body fat is distributed, metabolic markers such as blood pressure and blood glucose, physical fitness, and family history. A BMI figure therefore provides a starting point for a clinical conversation rather than a definitive verdict on someone's health.

Is BMI an accurate measure for everyone?

BMI is not equally accurate for all groups; it cannot distinguish fat from muscle and underestimates risk in people of South Asian, Chinese, Black African and Black Caribbean heritage. Waist circumference is used alongside BMI to give a more complete picture of metabolic risk.

BMI is not equally accurate for all population groups, and clinicians and public health bodies acknowledge its limitations. One of the most significant is that BMI cannot distinguish between fat mass and muscle mass. A person with a high proportion of lean muscle, such as an athlete, may register as overweight or obese by BMI despite having a low percentage of body fat and excellent metabolic health.

Ethnicity is another important consideration. NICE and NHS guidance recognises that people of South Asian, Chinese, Black African and Black Caribbean heritage tend to carry a higher proportion of body fat at a given BMI compared with white European populations, and face increased cardiometabolic risk at lower BMI thresholds. For these groups, a BMI of 23 or above may indicate increased risk, and a BMI of 27.5 or above may warrant the same clinical attention as a BMI of 30 in a white European adult.

BMI is also less informative in older adults, in whom muscle loss (sarcopenia) can mask excess fat, and in pregnant women, for whom standard adult ranges do not apply.

Waist circumference is increasingly used alongside BMI because central (abdominal) fat is more strongly linked to metabolic risk than fat stored elsewhere. NHS guidance uses two levels of risk for white European adults: increased risk (waist above 80 cm in women or above 94 cm in men) and very high risk (waist above 88 cm in women or above 102 cm in men). Lower thresholds apply to some ethnic groups; for example, for South Asian adults, a waist above 80 cm in women or above 90 cm in men is considered to indicate increased risk.^[3][6] Waist circumference is used alongside BMI to refine risk assessment, and central obesity with an otherwise normal BMI still warrants clinical attention.

For these reasons, BMI is best understood as one screening tool among several, rather than a standalone measure of health.

What should you do if your BMI falls outside the healthy range?

The first step is to speak with your GP, who will assess your full clinical picture rather than acting on BMI alone. NICE-recommended medicines such as semaglutide or tirzepatide may be considered where lifestyle interventions have not achieved sufficient benefit and clinical criteria are met.

If your BMI falls outside the healthy range, the most appropriate first step is to speak with your GP, who can assess your overall health in context and recommend evidence-based support. A BMI result on its own does not determine treatment; your GP will consider your full clinical picture, including blood pressure, blood glucose, cholesterol, waist circumference and any existing health conditions. If you have noticed unintentional weight loss, or have concerns about disordered eating or weight changes during pregnancy, it is particularly important to seek timely GP advice rather than relying on a BMI figure alone.

For people with a BMI in the overweight or obese range, NICE guidance recommends a structured approach that typically begins with dietary changes, increased physical activity and behavioural support. Referral to a specialist weight management service may be appropriate for those with a BMI of 40 or above, or 35 and above with a significant obesity-related condition.

Where lifestyle interventions alone have not achieved sufficient benefit, NICE has recommended certain medicines for chronic weight management. These include semaglutide (Wegovy) and tirzepatide (Mounjaro), both of which are MHRA-authorised for weight management in adults who meet specific clinical criteria.^[9][10] Wegovy is available in doses up to 2.4 mg weekly, with a higher 7.2 mg strength also authorised by the MHRA. Access to these medicines on the NHS depends on local Integrated Care Board commissioning decisions, and eligibility criteria apply.^[10] Bolt Pharmacy is a GPhC-registered online pharmacy in Great Britain offering online weight-management consultations, with prescriber review and pharmacist support, where a medicine may be considered if it is clinically appropriate following that consultation.

If your BMI is in the underweight range, your GP can investigate potential underlying causes and refer you to a dietitian or specialist service as needed. In either direction, professional guidance is preferable to self-directed action based on a BMI figure alone.

Scientific References

1. Calculate your body mass index (BMI) for adults.
2. Full guideline, section 2 – Identification and classification (NG246).
3. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
4. Obesity | Treatment summaries – BNF.
5. Overweight and obesity in adults.
6. Appendix A1: Summary of evidence from surveillance (NG246).
7. Waist circumference as a measure for indicating need for weight management. Lean ME et al..
8. Calculate your waist to height ratio.
9. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
10. Tirzepatide for managing overweight and obesity (TA1026).
11. Mounjaro | European Medicines Agency.
12. Wegovy, INN-semaglutide – EPAR Product Information.
13. Medicines regulator approves up to 7.2 mg dose of semaglutide/Wegovy for patients with obesity only.
14. Discussing results and referral | Overweight and obesity management (NG246).
15. Calculate body mass index (BMI) for children and teenagers.
16. Growth assessment – British Dietetic Association Paediatric Specialist Group.
17. Adolphe Quetelet (1796–1874) – the average man and indices of obesity. Eknoyan G..
18. Association of BMI with overall and cause-specific mortality. Bhaskaran K et al..
19. Malnutrition.
20. Bone mineral density and body composition in underweight elderly subjects. Coin A et al..

Frequently Asked Questions